Cardiac Toxicity of Methylphenidate
- 22 February 1962
- journal article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 266 (8) , 400-401
- https://doi.org/10.1056/nejm196202222660807
Abstract
METHYLPHENIDATE, a cerebrocortical stimulant, has been studied in a wide variety of clinical settings for its mood-elevating effects. Recently, it has been used in the treatment of drug-induced lethargy and oversedation.1 Mild side effects such as anorexia, flushing, dizziness, palpitations, insomnia, headache and blood-pressure changes in both directions have been observed.2 , 3 The episode of a rapid paroxysm of atrial fibrillation that followed the intravenous use of methylphenidate, illustrated in the case reported below, is believed to be the first so documented.Case ReportsCase 1. H.B., a 60-year-old man, was admitted to the Philadelphia General Hospital on August 8, 1961, . . .Keywords
This publication has 2 references indexed in Scilit:
- Accidental Ingestion and Overdosage Involving Psychopharmacologic DrugsNew England Journal of Medicine, 1960
- Treatment of narcolepsy with RitalinNeurology, 1959